Diabetes, Vol 49, Issue 7 1137-1141, Copyright © 2000 by American Diabetes Association

ARTICLES

Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells

J Seissler, TB Nguyen, G Aust, H Steinbrenner and WA Scherbaum
Diabetes Research Institute, University of Dusseldorf, Germany. sei@dfi.uni-duesseldorf.de

IA-2, a member of the protein tyrosine phosphatase family, represents a major target autoantigen in type 1 diabetes. To study the regulation of IA-2 gene expression, we used INS-1 insulinoma cells to analyze beta-cell signal transduction pathways as well as the effect of metabolic and hormonal factors involved in the regulation of the insulin secretory pathway. Quantitative competitive reverse transcriptase-polymerase chain reaction revealed that an increase of cellular cAMP mediated by forskolin (10 micromol/l, 24 h) or 3-isobutyl-1-methylxanthine (100 micromol/l, 24 h) induced maximal stimulation of IA-2 mRNA levels (451 +/- 85 and 338 +/- 86% compared with basal conditions; P < 0.001). In contrast, activation of protein kinase C (PKC) by short-term treatment with phorbol 12-myristate 13-acetate (PMA) (1 micromol/l, 6 h) did not alter IA-2 expression, whereas depletion of PKC by prolonged culturing (24 h) exerted a significant inhibition (57 +/- 24%; P < 0.05). cAMP-dependent upregulation was confirmed by the findings that glucagon (10 micromol/l, 24-48 h) increased levels of IA-2 mRNA (190 +/- 35%; P < 0.05), whereas short-term incubation with high glucose concentration showed no effect. However, prolonged incubation in high glucose (21 mmol/l) induced a time- and dose-dependent increase of IA-2 mRNA expression, reaching maximal values after 144 h (285 +/- 68%; P < 0.05). These studies demonstrate that stimuli of insulin secretion that operate by activation of adenylate cyclase generating cAMP significantly increase IA-2 gene expression. In contrast, activation of PKC by high glucose concentration or PMA exerted no effect, suggesting that IA-2 gene expression is not simply coupled to insulin secretion, but may be involved in the fine regulation of beta-cell function. These findings may be important to clarify the function of IA-2 in beta-cells and elucidate mechanisms involved in the induction of autoimmunity to IA-2.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Allagnat, D. Martin, D. F. Condorelli, G. Waeber, and J.-A. Haefliger Glucose represses connexin36 in insulin-secreting cells J. Cell Sci., November 15, 2005; 118(22): 5335 - 5344. [Abstract] [Full Text] [PDF]

				F. Schuit, D. Flamez, A. De Vos, and D. Pipeleers Glucose-Regulated Gene Expression Maintaining the Glucose-Responsive State of {beta}-Cells Diabetes, December 1, 2002; 51(90003): S326 - 332. [Abstract] [Full Text] [PDF]

				H. Steinbrenner, T.-B.-T. Nguyen, U. Wohlrab, W. A. Scherbaum, and J. Seissler Effect of Proinflammatory Cytokines on Gene Expression of the Diabetes-Associated Autoantigen IA-2 in INS-1 Cells Endocrinology, October 1, 2002; 143(10): 3839 - 3845. [Abstract] [Full Text] [PDF]

				K. Lobner, H. Steinbrenner, G. A. Roberts, Z. Ling, G.-C. Huang, S. Piquer, D. G. Pipeleers, J. Seissler, and M. R. Christie Different Regulated Expression of the Tyrosine Phosphatase-Like Proteins IA-2 and Phogrin by Glucose and Insulin in Pancreatic Islets: Relationship to Development of Insulin Secretory Responses in Early Life Diabetes, October 1, 2002; 51(10): 2982 - 2988. [Abstract] [Full Text] [PDF]

				K. Saeki, M. Zhu, A. Kubosaki, J. Xie, M. S. Lan, and A. L. Notkins Targeted Disruption of the Protein Tyrosine Phosphatase-Like Molecule IA-2 Results in Alterations in Glucose Tolerance Tests and Insulin Secretion Diabetes, June 1, 2002; 51(6): 1842 - 1850. [Abstract] [Full Text] [PDF]